(Q40109714)

English

Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. (English)

1 reference

Europe PubMed Central

17 September 2017

radiation therapy

0 references

oligodendrocyte

1 reference

based on heuristic

inferred from title

object named as

Minesh Mehta

6

0 references

Peter C. Burger

2

object named as

Peter C Burger

1 reference

Europe PubMed Central

17 September 2017

J Gregory Cairncross

4

object named as

J Gregory Cairncross

1 reference

Europe PubMed Central

17 September 2017

author name string

Caterina Giannini

1

1 reference

Europe PubMed Central

17 September 2017

Brian A Berkey

3

1 reference

Europe PubMed Central

17 September 2017

Robert B Jenkins

5

1 reference

Europe PubMed Central

17 September 2017

Walter J Curran

7

1 reference

Europe PubMed Central

17 September 2017

Ken Aldape

8

1 reference

Europe PubMed Central

17 September 2017

publication date

26 March 2008

1 reference

Europe PubMed Central

17 September 2017

Brain Pathology

1 reference

Europe PubMed Central

17 September 2017

18

1 reference

Europe PubMed Central

17 September 2017

360-369

1 reference

Europe PubMed Central

17 September 2017

3

1 reference

Europe PubMed Central

17 September 2017

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Correlation between genetic alteration and long‐term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Molecular pathogenesis of oligodendroglial tumors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Loss of heterozygosity for loci on chromosome arms 1p and 10q in oligodendroglial tumors: relationship to outcome and chemosensitivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00129.X

21 January 2018

Identifiers

10.1111/J.1750-3639.2008.00129.X

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40109714&oldid=1992881781"